In a triple-blinded RCT, 51 men aged ≥65 with type 2 diabetes were randomized to resistance training plus either a control, protein supplementation (P), or synbiotic-plus-protein (SP) for the intervention period. Forty completers reached final analysis. The protein group showed superior gains in muscle strength, reduced insulin resistance (HOMA-IR proxy), and lower oxidative damage from heme-iron species. All groups improved physical performance and redox balance via elevated uric acid and reduced plasma iron. Elevated IFN-γ and IL-6 in the protein group were interpreted as adaptive rather than pathological responses. Critically, adding synbiotics produced no measurable advantage over protein and resistance training alone.
The null synbiotic result is noteworthy given strong mechanistic rationale linking gut dysbiosis to inflammaging in T2DM. However, with only 14 completers in the SP arm, the study is severely underpowered to detect modest microbiome-mediated effects — a limitation the authors acknowledge implicitly. The all-male cohort also limits generalizability, particularly to older women where sarcopenia trajectories differ markedly. The IFN-γ and IL-6 interpretation as adaptive deserves scrutiny; context-dependent cytokine elevation in insulin-resistant populations can be genuinely dual-edged. What this trial does confirm, with reasonable rigor, is that protein supplementation meaningfully amplifies resistance training's anabolic and metabolic benefits in older diabetic men — a confirmatory but clinically useful finding for practitioners designing geriatric exercise-nutrition programs. Synbiotic adjuncts may still warrant adequately powered future trials.
